USE OF URINARY KALLIDINOGENASE IN COMBINATION WITH RIVAROXABAN IN PATIENTS WITH BRAIN INFARCTION

Avezova , Sadokat Yuldashevna

Гуманитар ва табиий фанлар журнали · 2024-yil

Annotatsiya

Stroke is a major burden worldwide due to unsatisfactory conventional treatments available today. Disability from a stroke ranks first among the causes of primary disability. To date, the introduction of new methods of treatment contributes to the success of stroke treatment and greater patient survival. The use of urinary callidinogenase (Kalgen 0.15 PNA) in combination with rivaroxaban as part of complex therapy for patients with cerebral infarction has an etiopathogenetically effective and rapid recovery of nervous function.

Maqola ma’lumotlari
MualliflarAvezova , Sadokat Yuldashevna
JurnalГуманитар ва табиий фанлар журнали
Nashr sanasi2024-04-15
Son9
Betlar153-155
TilRus

Kalit so‘zlar

ischemic stroke, urinary callidinogenase, rivaroxaban, hemostasis.

Ilmiy soha

Гуманитар ва табиий фанлар журнали jurnalidan boshqa maqolalar

Гуманитар ва табиий фанлар журнали — barcha maqolalar